Drug Profile
Interleukin-4 Trap - Regeneron
Alternative Names: IL-4 antagonist - Regeneron; IL-4 Trap - Regeneron; Interleukin-4 antagonist - RegeneronLatest Information Update: 20 Jun 2002
Price :
$50
*
At a glance
- Originator Regeneron Pharmaceuticals
- Class
- Mechanism of Action Interleukin 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Hypersensitivity
Most Recent Events
- 20 Jun 2002 Discontinued - Preclinical for Allergy in USA (unspecified route)
- 20 Jun 2002 Discontinued - Preclinical for Asthma in USA (unspecified route)
- 07 Jul 2000 Preclinical development for Allergy in USA (Unknown route)